These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24339138)
21. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years. Zimmerman M; Holst CG; Clark HL; Multach M; Walsh E; Rosenstein LK; Gazarian D CNS Drugs; 2016 Dec; 30(12):1209-1218. PubMed ID: 27541608 [TBL] [Abstract][Full Text] [Related]
22. DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder. Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Jun TY; Serretti A J Int Med Res; 2012; 40(1):258-65. PubMed ID: 22429365 [TBL] [Abstract][Full Text] [Related]
23. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [TBL] [Abstract][Full Text] [Related]
24. The high prevalence of bipolar spectrum disorders in young adults with recurrent depression: toward an innovative diagnostic framework. Smith DJ; Harrison N; Muir W; Blackwood DH J Affect Disord; 2005 Feb; 84(2-3):167-78. PubMed ID: 15708414 [TBL] [Abstract][Full Text] [Related]
25. "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Ghaemi SN; Ko JY; Goodwin FK Can J Psychiatry; 2002 Mar; 47(2):125-34. PubMed ID: 11926074 [TBL] [Abstract][Full Text] [Related]
26. Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety. Schaffer A; Cairney J; Veldhuizen S; Cheung A; Levitt A J Clin Psychiatry; 2007 Nov; 68(11):1785-92. PubMed ID: 18052573 [TBL] [Abstract][Full Text] [Related]
27. Discriminating bipolar depression from major depressive disorder with polygenic risk scores. Liebers DT; Pirooznia M; Ganna A; ; Goes FS Psychol Med; 2021 Jul; 51(9):1451-1458. PubMed ID: 32063240 [TBL] [Abstract][Full Text] [Related]
28. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder. Tansey KE; Rucker JJ; Kavanagh DH; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans DM; Hauser J; Henigsberg N; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Lewis G; Kapur S; McGuffin P; Uher R Pharmacogenomics J; 2014 Aug; 14(4):395-9. PubMed ID: 24445990 [TBL] [Abstract][Full Text] [Related]
29. Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms. Halmai Z; Dome P; Vereczkei A; Abdul-Rahman O; Szekely A; Gonda X; Faludi G; Sasvari-Szekely M; Nemoda Z J Affect Disord; 2013 Aug; 150(1):104-9. PubMed ID: 23602648 [TBL] [Abstract][Full Text] [Related]
30. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Amare AT; Schubert KO; Hou L; Clark SR; Papiol S; Cearns M; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Brichant-Petitjean C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Del Zompo M; DePaulo JR; Étain B; Jamain S; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe JR; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy SL; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Pfennig A; Potash JB; Reif A; ; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt SH; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Baune BT Mol Psychiatry; 2021 Jun; 26(6):2457-2470. PubMed ID: 32203155 [TBL] [Abstract][Full Text] [Related]
31. Sub-threshold bipolar disorder in medication-free young subjects with major depression: Clinical characteristics and antidepressant treatment response. Koirala P; Hu B; Altinay M; Li M; DiVita AL; Bryant KA; Karne HS; Fiedorowicz JG; Anand A J Psychiatr Res; 2019 Mar; 110():1-8. PubMed ID: 30579045 [TBL] [Abstract][Full Text] [Related]
32. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants. Chang HS; Won E; Lee HY; Ham BJ; Lee MS Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202 [TBL] [Abstract][Full Text] [Related]
33. Using Clinical Characteristics to Identify Which Patients With Major Depressive Disorder Have a Higher Genetic Load for Three Psychiatric Disorders. Verduijn J; Milaneschi Y; Peyrot WJ; Hottenga JJ; Abdellaoui A; de Geus EJC; Smit JH; Breen G; Lewis CM; Boomsma DI; Beekman ATF; Penninx BWJH Biol Psychiatry; 2017 Feb; 81(4):316-324. PubMed ID: 27576130 [TBL] [Abstract][Full Text] [Related]
34. Do no harm: a paradigm shift in the unchecked use of antidepressants. Morrissette DA CNS Spectr; 2017 Apr; 22(2):118-119. PubMed ID: 28179047 [No Abstract] [Full Text] [Related]
35. Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. Barbuti M; Mazzarini L; Vieta E; Azorin JM; Angst J; Bowden CL; Mosolov S; Young AH; Perugi G; J Affect Disord; 2019 Sep; 256():250-258. PubMed ID: 31195243 [TBL] [Abstract][Full Text] [Related]
36. Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder. Saatcioglu O; Erim R; Tomruk N; Oral T; Alpay N J Affect Disord; 2011 Nov; 134(1-3):85-90. PubMed ID: 21632117 [TBL] [Abstract][Full Text] [Related]
37. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review. Mistry S; Harrison JR; Smith DJ; Escott-Price V; Zammit S J Affect Disord; 2018 Jul; 234():148-155. PubMed ID: 29529547 [TBL] [Abstract][Full Text] [Related]
38. Genome-wide association studies in pharmacogenomics of antidepressants. Lin E; Lane HY Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525 [TBL] [Abstract][Full Text] [Related]
39. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687 [TBL] [Abstract][Full Text] [Related]
40. Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample. Calabrò M; Mandelli L; Crisafulli C; Lee SJ; Jun TY; Wang SM; Patkar AA; Masand PS; Benedetti F; Han C; Pae CU; Serretti A Adv Ther; 2018 Oct; 35(10):1656-1670. PubMed ID: 30178121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]